Establishing strong international partnerships starts with clear expectations and well-structured agreements. Join EDPNC on July 16 for a 90-minute strategy session covering building productive and ...

Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...

This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S.

Over the past year my colleague Nandini Mendu, Ph.D., senior director, agriculture sector development, has been working on a strategic project looking into North Carolina’s animal health and nutrition ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Novartis, a major contributor to North Carolina’s reputation as “Vaccine Central,” is stepping up its game again. Not only is it planning to expand its $1 billion Holly Springs biomanufacturing campus ...

Mitey smart critters In an interview with NCBiotech, Rueppell said one reason it’s important to think about helping bees help themselves is that the varroa mites are already developing resistance to ...

Any bioscience or other technology company in North Carolina that has received a specified type of federal grant for research and development has until Dec. 1 to apply for matching state funds through ...

Each pallet of COVID test swabs represented over 28,000 swabs. At the peak of the pandemic, Andersen Scientific was sterilizing swabs for four companies – frequently three pallets a week, and at times ...

Around the world, small businesses have taken a hit during the COVID-19 pandemic. Life sciences companies have been challenged on a personal and professional level, facing the same economic crisis as ...